Disfunção Erétil Deixou De Ser Tabu?

Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. 26. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy. Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required. 34. Jones J, Bashir T, Olney J, Wheatley T. Cabergoline treatment for a large macroprolactinoma throughout pregnancy. Successful treatment of a large macroprolactinoma with cabergoline during pregnancy. 40. Laloi-Michelin M, Ciraru-Vigneron…